Owens & Minor, Inc. (NYSE:OMI – Get Free Report) has been assigned a consensus rating of “Hold” from the seven research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $22.29.
Several analysts have recently weighed in on OMI shares. Leerink Partnrs restated a “market perform” rating on shares of Owens & Minor in a research report on Monday, February 26th. SVB Leerink started coverage on shares of Owens & Minor in a research note on Monday, February 26th. They set a “market perform” rating and a $24.00 target price on the stock. StockNews.com raised shares of Owens & Minor from a “hold” rating to a “buy” rating in a research note on Wednesday, February 21st. UBS Group lowered their price target on shares of Owens & Minor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, January 29th. Finally, TheStreet raised shares of Owens & Minor from a “d+” rating to a “c-” rating in a report on Monday, March 4th.
Read Our Latest Analysis on Owens & Minor
Insider Activity at Owens & Minor
Hedge Funds Weigh In On Owens & Minor
A number of hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of Owens & Minor by 1.4% during the first quarter. BlackRock Inc. now owns 11,896,845 shares of the company’s stock worth $523,700,000 after acquiring an additional 168,282 shares during the last quarter. FMR LLC boosted its position in shares of Owens & Minor by 10.6% during the third quarter. FMR LLC now owns 11,479,209 shares of the company’s stock worth $185,504,000 after acquiring an additional 1,103,275 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Owens & Minor by 0.3% during the third quarter. Vanguard Group Inc. now owns 8,592,904 shares of the company’s stock worth $138,861,000 after acquiring an additional 25,891 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Owens & Minor by 1.0% during the first quarter. Wellington Management Group LLP now owns 7,552,955 shares of the company’s stock worth $332,482,000 after acquiring an additional 77,252 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C boosted its position in shares of Owens & Minor by 35.6% during the third quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock worth $103,990,000 after acquiring an additional 1,690,000 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors.
Owens & Minor Stock Up 5.2 %
OMI opened at $27.95 on Thursday. The company has a 50 day moving average of $22.74 and a 200 day moving average of $19.64. The company has a market cap of $2.14 billion, a PE ratio of -51.76, a price-to-earnings-growth ratio of 0.81 and a beta of 0.41. Owens & Minor has a 12 month low of $12.64 and a 12 month high of $27.99. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05.
Owens & Minor (NYSE:OMI – Get Free Report) last released its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 EPS for the quarter, topping the consensus estimate of $0.66 by $0.03. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 11.62%. The company had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.67 billion. During the same period last year, the firm earned $0.28 EPS. Owens & Minor’s revenue for the quarter was up 4.1% on a year-over-year basis. On average, sell-side analysts expect that Owens & Minor will post 1.54 EPS for the current year.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Read More
- Five stocks we like better than Owens & Minor
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Best Bear Market Funds: Top 3 Investment Options to Consider
- How to Buy Cheap Stocks Step by Step
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- How to Use Stock Screeners to Find Stocks
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.